Equities
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

As of last trade, Novozymes A/S (NVZMF:PKL) traded at 62.66, 16.90% above the 52 week low of 53.60 set on Feb 20, 2025.
52-week range
Today
53.60Feb 20 202575.97Jun 12 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open62.66
High62.66
Low62.66
Bid--
Offer--
Previous close62.65
Average volume534.33
Shares outstanding414.56m
Free float295.25m
P/E (TTM)--
Market cap160.38bn DKK
EPS (TTM)--
Annual div (ADY)0.6784
USD
Annual div yield (ADY)1.08%
Div ex-dateAug 26 2025
Div pay-dateAug 27 2025
Data delayed at least 15 minutes, as of Feb 12 2026 16:41 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.